When ductal carcinoma in situ is not identified

This phrase may appear in a biopsy or surgical pathology report. It means the examined specimen did not contain ductal carcinoma in situ. It does not by itself explain whether the sample matched the mammogram finding, whether another abnormality was present, or whether the specimen was large enough to answer the clinical question.

A radiologist and pathologist may compare the imaging appearance with the tissue result. If those findings do not agree, the team may recommend repeat sampling, a different biopsy approach, or short-interval imaging. A report can also use this wording when the question concerns a specific area and other tissue findings are described separately.

Ask the clinician who arranged the test to explain the final diagnosis in plain language and whether the result is considered concordant with the mammogram. Keep copies of the imaging and pathology reports. Follow the recommended review even when the wording sounds reassuring, because follow-up depends on the original finding, the quality of the sample, and any ongoing breast change.

If another procedure is suggested, ask what area it targets and what question it is intended to answer. Do not stop prescribed medicines or cancel imaging without discussing it with the treating team.

Seek prompt advice for fever, spreading redness, drainage, increasing swelling, or worsening pain after a biopsy. Arrange assessment for a new or enlarging breast or underarm lump, bloody nipple discharge, nipple inversion, skin dimpling, or a persistent change in shape. Sudden heavy bleeding, fainting, chest pain, or breathlessness needs urgent medical attention.

What exactly was examined, and what diagnosis was found instead? Does the tissue result match the mammogram? Is further sampling or imaging needed? When should my next review occur? Which new breast changes should prompt an earlier appointment?